Prediction of prognosis with neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and pathological parameters in operated gastric cancer

Main Article Content

Ozlem Mermut
Berrin Inanc


Objective: Inflammatory markers are of prognostic importance in many malignancies. This study aimed to examine the effects of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and pathological parameters on survival in preoperative complete blood counts in patients with operated gastric cancer.

Material and Methods: Between 2012 and 2017, 281 patients were analyzed after total/subtotal gastrectomy. According to the ROC curve, we determined the cut-off values for NLR as 2.5 and PLR as 158. Overall survival (OS) was calculated from surgery to the last interview or to death.

Results: In univariate analysis age ≥ 55 (p = 0.028), non-adeno hystology (p = 0.003), lenfovascular invasion (LVI) positivity (p = 0.003), perineural invasion (PNI) positivity (p < 0.001), T 3-4 stage (p = 0.006), lymph node involvement (LN) 2-3 (p < 0.001), metastatic stage (p <  0.001), NLR ≥ 2.5 ( p<0.001) and PLR ≥ 158 (p < 0.001) were statistically significant for OS. In multivariate analysis age (HR 0.652, 95% CI: 0.475-0.895; p = 0.008), PNI positivity (HR 0.493, 95% CI: 0.337-0.720; p<0.001), more lymph node involvement (HR: 0.608, 95% CI:0.412-0.896, p = 0.012), metastatic stage (HR 0.377, 95% CI: 0.265-0.537; p < 0.001) and PLR ≥ 158  (HR: 0.610; 95% CI: 0.433-0.859; p = 0.005) were found to be independent prognostic factors affecting OS.

Conclusion: Age ≥ 55, PNI positivity, more lymph node involvement, metastatic stage, and PLR ≥ 158  are independent prognostic factors for shorter overall survival. Given the high morbidity and mortality of gastric cancer, besides classical known prognostic factors, parameters such as preoperative PLR may have benefits for forecast the prognosis of gastric cancer.


Download data is not yet available.

Article Details

How to Cite
Mermut, O., & Inanc, B. (2020). Prediction of prognosis with neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and pathological parameters in operated gastric cancer. Medical Science and Discovery, 7(11), 703-708.
Research Article


1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5):E359-E386.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016; 66 (1):7-30.

3. Huang L, Liu S, Lei Y, et al. Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget 2016; 7(28):44185-93.

4. Lohinai Z, Bonanno L, Aksarin A, et al. Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer. PeerJ. 2019; 7:e7232.

5. Mermut O, Inanc B. The effect of indicators of systemic inflammatory response on survival in glioblastoma multiforme. Turk Neurosurg. 2019;10.5137/1019-5149. JTN.27068-19.1.

6. Wang D, Bai N, Hu X, et al. Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC. PeerJ. 2019; 7:e7132.

7. Yin X, Wu L, Yang H, et al. Prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with ovarian cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(45):e17475.

A. K. Olsson and J. Cedervall. The pro-inflammatory role of platelets in cancer. Platelets. 2018;29 (6):569-73.

8. R. Grecian, M. K. B. Whyte, and S. R. Walmsley.The role of neutrophils in cancer.Br Med Bull. 2018;128 (1):5-14.

9. Takatsu Y, Hiki N, Nunobe S, et al. Clinicopathological features of gastric cancer in young patients. Gastric Cancer. 2016;19:472-8.

10. Chen J, Chen J, Xu Y, et al. Impact of Age on the Prognosis of Operable Gastric Cancer Patients: An Analysis Based on SEER Database. Medicine (Baltimore). 2016; 95(24):e3944.

11. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008; 44(16):2397-403.

12. Fléjou JF. Classification OMS 2010 des tumeurs digestives: la quatrième édition [WHO Classification of digestive tumors: the fourth edition]. Ann Pathol. 2011; 31(5 Suppl):27-31.

13. Feng F, Liu J, Wang F, et al. Prognostic value of differentiation status in gastric cancer. BMC Cancer. 2018;18(1):865.

14. Lee SY, Yoshida N, Dohi O, et al. Differences in prevalence of Lymphovascular invasion among early gastric cancers between Korea and Japan. Gut Liver. 2017;11 (3):383-91.

15. Zhang CD, Ning FL, Zeng XT, et al. Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric Cancer patients under 70 years of age: A retrospective analysis. Int J Surg. 2018; 53:214-20.

16. Wu L, Liang Y, Zhang C, et al. Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent. Chin J Cancer Res. 2019; 31(5):785-96.

17. De Franco L, Marrelli D, Voglino C, et al. Prognostic value of perineural invasion in resected gastric cancer patients according to Lauren histotype. Pathol. Oncol. Res. 2018; 24(2): 393-400.

18. Hwang JE, Hong JY, Kim JE, et al. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy. Jpn J Clin Oncol. 2015;45(6):541-6.

19. Jiao XG, Deng JY, Zhang RP, et al. Prognostic value of number of examined lymph nodes in patients with node-negative gastric Cancer. World J Gastroenterol. 2014; 20 (13):3640-8.

20. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-e503.

21. Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759-71.

22. Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem. 2000;275(3):1521-4.

23. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539-45.

24. Sica A. Role of tumour-associated macrophages in cancer-related inflammation. Exp Oncol. 2010;32(3):153-8.

25. Wang DS, Luo HY, Qiu MZ, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29(5):3092-100.

26. Shoda K, Komatsu S, Ichikawa D,et al. Thrombocytosis associated with poor prognosis in patients with gastric cancer. Gan To Kagaku Ryoho. 2015;42(12):1980-2.

27. Chen Y, Zhang L, Liu WX, Liu XY. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer. Asian Pac J Cancer Prev. 2015;16(3):933-9.

28. Yu L, Lv CY, Yuan AH, et al. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer. World J Gastroenterol. 2015; 21 (20):6280-6.

29. Deng Q, He B, Liu X, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med. 2015;13(1):66.

30. Jiang N, Deng JY, Liu Y, et al. The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers 2014; 19(6):444-51.

31. Zhang Y, Lu JJ, Du YP, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer. Medicine (Baltimore). 2018; 97(12):e0144.

32. Cao W, Yao X, Cen D, et al. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20:16.

33. Gu L, Wang M, Cui X, et al. Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection. BMC Surg. 2020;20(1):219.

34. Zhang X, Zhao W, Yu Y, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020;18(1):191.

35. Zhou X, Xu L, Huang Z, et al. The hematologic markers as prognostic factors in patients with resectable gastric cancer. Cancer Biomark. 2016;17(3):359-67.